objeCtives: Assess the consumer perception of communication with their HCPs and the information clarity during their recent medical visit when a new medication was prescribed. Methods: A cross-sectional online survey of consumers (patients and caregivers) was conducted (FDA cooperative-agreement #5U18FD004653-01) in Nov-Dec 2013 using a consumer panel in the U.S. A geographically diverse sample of consumers taking prescription medication(s) daily in the past 6 months to manage > = 1 chronic disease condition, or who had a primary responsibility for helping another adult taking prescription medication was recruited. Survey collected medication-taking and information-seeking behavior, and personal experience with and receipt of medication warnings/safety information. Descriptive statistics are reported. Results: Two thousand consumers (1600 patients/400 caregivers) participated. Positive attributes concerning HCP communication and information clarity (specific to medication being prescribed and their risk/safety included: comfortable asking HCP questions about the medication (90%), HCP made me feel confident the medication was the best to treat my condition (86%), HCP addressed fears/concerns about medication (84%), HCP informed me of medication side-effects (75%). Negative attributes/perceptions included: I had concerns about medication safety (44%), it was hard to follow-up with HCP via email/phone with medication-related questions (44%), HCP did not spend enough time to discuss medication (33%), HCP seemed too quick to prescribe medication (31%), I don't know what do to if I miss medication dose or took too much (27%), HCP used medical terms that were confusing (26%). These perceptions varied by age, number of comorbidities and whether the consumer was a patient or a caregiver. ConClusions: A diversity of positive and negative perceptions of HCP communication and information clarify was observed concerning recently prescribed medications. Factors influencing the negative perceptions and the modalities to address them warrants scrutiny.objeCtives: To evaluate the perceptions of consumers and HCPs concerning the receipt and delivery of medication risk/safety information. Methods: A crosssectional online survey of consumers (patients and caregivers) and HCPs was conducted (FDA cooperative-agreement #5U18FD004653-01) in Nov-Dec 2013 using online U.S panels. Two geographically diverse samples were recruited: consumers taking prescription medication(s) daily in the past 6 months to manage > = 1 chronic disease condition, or who had a primary responsibility for helping another adult taking prescription medication; and HCPs (primary care physicians (PCPs), pharmacists, nurse practitioners (NPs) and physician assistants (PAs)) spending > = 50% of time in direct ambulatory patient care (PCP/PA/NP) or working in a retail pharmacy (pharmacists), with > = 2 yrs of practice experience and seeing/consulting > = 20 patients/wk. HCP survey collected beliefs about medication risks, information seeking behavior and communication o...
with usual activities and 23.6% of patients with mobility. Visual Analogue Scale (VAS) QoL scores for quiescent and active UC patients were 78.41 (14.89) and 69.50 (19.41) (p= 0.0205), respectively. Quiescent patients had insignificantly better scores in all SIBDQ elements (global, systemic, social, bowel, emotional), global scores for patients with quiescent and active UC were 5.08 (1.31) and 4.75 (1.26) respectively. WPAI:UC indicated high levels of unemployment (40.7%). On average: work time missed (12.25% (27.30)), impairment while working (20.46% (25.85)) and overall work impairment (26.47% (32.21)). Scores for impairment of non-work activity for quiescent and active patients were 17.10% (25.45) and 27.39% (28.62) (p= 0.0244), respectively. ConClusions: Patients with active UC demonstrated lower QoL measured by VAS and greater impairment of non-work activities. UC patients experienced a high percentage of unemployment and significant productivity loss.
Objectives: To investigate the mental health of rheumatic diseases patients and explore the effect of psychotherapy for the mental health status in rheumatism inpatients. MethOds: 1. To compare the mental health status in rheumatism inpatients with normal by SCL-90 score. 2. 66 inpatients with rheumatism were recruited in the study and randomly divided into study group (n= 33) and control group (n= 33). The patients in the study group accepted psychotherapy and pharmacotherapy, and control group only accepted pharmacotherapy. 3. Six weeks later, the effect of psychotherapy to rheumatism inpatients were assessed by comparing the score of SCL-90 between the two groups. Results: 1. The SCL-90 score significantly increased in rheumatism inpatients group compared with normal group: rheumatism inpatients group (152.8±35.9) and normal group (129.9±38.7), (P< 0.05). 2. Six weeks later, the SCL-90 sore of study group was lower than that of control group. 3. The SCL-90 score significantly reduced after psychological treatment. cOnclusiOns: The mental health status of rheumatism patients can not be ignored, because the patients have varying degrees of mental psychotic symptoms. The psychotherapy can improve the mental health status in rheumatism patients and can help the recovery of the patients.
patients is sensory neuropathy (33%) followed by mucositis/stomatitis (27%), risk of serious infection (16%), diarrhea (13%), alopecia (4%), nausea/vomiting (3%), and fatigue (3%). Conclusions: The choice of chemotherapy regime should acknowledge patients' preferences to different side effects. Our small sample size warrant further research to confirm the findings.
additional 6% to 11% of variance), however carer characteristics only emerged as a significant predictor of the health burden scale (11% of explained variance). Key individual predictor variables of burden domains included patients' general health status, presence of a stoma, and the time costs associated with care. ConClusions: These results highlight the need to recognise the role that various factors play in determining carer burden. While certain aspects of carer characteristics influence this, patient health and care-related activities have the most significant impact pointing to a need to deliver effective support to those most at risk of carer burden.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.